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Gastric cancer (GC) is a common aggressive malignant tumor with high incidence and mortality 
worldwide. GC is classified into intestinal and diffuse types according to the histo-morphological 
features. Because of distinctly different clinico-pathological features, new cancer therapy strategies and 
in vitro preclinical models for the two pathological variants of GC is necessary. Since extracellular matrix 
(ECM) influence the biological behavior of tumor cells, we hypothesized that GC might be more similarly 
modeled in 3D with matrix rather than in 2D. Herein, we developed a microfluidic-based a three-
dimensional (3D) in vitro gastric cancer model, with subsequent drug resistance assay. AGS (intestinal 
type) and Hs746T (diffuse type) gastric cancer cell lines were encapsulated in collagen beads with 
high cellular viability. AGS exhibited an aggregation pattern with expansive growth, whereas Hs746T 
showed single-cell-level infiltration. Importantly, in microtumor models, epithelial-mesenchymal 
transition (EMT) and metastatic genes were upregulated, whereas E-cadherin was downregulated. 
Expression of ß-catenin was decreased in drug-resistant cells, and chemosensitivity toward the 
anticancer drug (5-FU) was observed in microtumors. These results suggest that in vitro microtumor 
models may represent a biologically relevant platform for studying gastric cancer cell biology and 
tumorigenesis, and for accelerating the development of novel therapeutic targets.
Gastric cancer (GC) is an aggressive malignant tumor with high incidence and mortality in worldwide despite 
recent advances in anti-cancer drugs1. Lauren’s classification distinguishes the following two types of gastric can-
cer according to the morphological aspects of the tumor: (1) intestinal type (with a tubular and mucinous ade-
nocarcinoma) and (2) diffuse type (poorly differentiated carcinoma). These morphological differences indicate 
distinct clinical phenotypes based on the presence of different molecular mechanisms2–4. Most cancer cells in the 
diffuse type are scattered and accompanied by marked stromal reactions2,3. Diffuse type GC is usually associated 
with higher mortality5.
To most effectively study the tumorigenesis and test the anti-cancer drugs, preclinical tumor models are 
required to reflect in vivo tumor microenvironments6–8. To date, great improvements in the construction of can-
cer models have been made using in vitro 3D physiologically relevant culture systems9–13. In general, in vitro 3D 
microtumor models can represent cell-cell and cell-extracellular matrix (ECM) interactions that are natural char-
acteristics of in vivo microenvironment14–17. In cancer biology, the ECM regulates the physical and biochemical 
properties of the tumor microenvironment, which modulates cancer cell polarity, migration and signaling18–20. 
Stromal components of the ECM influence the biological behavior of tumor cells, especially ECM might impact 
more on diffuse type gastric cancer since it is existed in tumor environment with more abundant ECM compared 
to intestinal. Moreover, the ECM microenvironment play a primary role in the control of epithelial–mesenchy-
mal transition (EMT) responses, which is a physiological process in which epithelial cells acquire motile and 
invasive characteristics21. In particular, the ECM in gastric cancer has been associated with increased mortality 
in patients22. In addition, EMT is an important event in the gastric cancer invasion–metastasis cascade whereby 
epithelial cells lose polarity along with cell–cell adhesion23,24.
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Currently, many researchers are promoting 3D platforms for studying the interactions of tumor cells with the 
microenvironment and identifying the key factors that regulate the mode of migration and EMT responses25,26. 
However, the representative histological subtypes of gastric cancer (intestinal and diffuse) have not yet been well 
characterized in 3D models. As a valuable 3D model for the high-throughput evaluation of drugs, cell-laden ECM 
hydrogels can provide a more comprehensive assessment of tumor responses to therapeutic strategies, and enable 
the study of ECM-related tumor microenvironments.
Here, we demonstrated a droplet-based microtumor model to assess cell-ECM interactions and drug resist-
ances of different types of gastric cancer, using the AGS (intestinal type) and Hs746T (diffuse type) cell lines. 
With this model, we performed a systematic comparison between 2D and 3D system in cultured cell charac-
teristics and functional assessment. Type 1 collagen, which consisted of fibrous proteins and one of abundant 
ECM components in gastric tissue. By using a microfluidic-based droplet formation, we obtained well-controlled 
cell-encapsulated ECM microbeads. In both cell types, the expression of pro-metastatic genes, such as those 
involved with EMT, were upregulated in our model compared with 2D monolayer culture. Moreover, we con-
firmed that the drug resistance-related molecules were significantly up-regulated in 3D microtumor model of 
both cancer types; thus, the chemosensitivity against the anticancer drug, 5-fluorouracil (5-FU) is correlated with 
the expression of drug-resistance genes and proteins.
Results
Generation of cell-laden collagen bead. Figure 1a shows a schematic illustration of the design of the 
microfluidic device. The polydimethylsiloxane (PDMS)-based microfluidic device is functionally composed of 
an aqueous channel with gastric cancer cells, collagen solution and oil. The dimension of microfluidic device is 
described in Supplementary Figure S1. To generate a biocompatible procedure for forming cell-laden microdrop-
lets, we utilized a fluorinated oil (HFE7500) as oil phase, which has high oxygen permeability to ensure an ade-
quate supply of oxygen during collagen gelation27. The microdroplets spontaneously formed at a cross junction 
due to their different interfacial properties28. First, 4 mg/ml collagen type 1 with GC cells and oil were injected 
into the device. Microdroplets with tunable and uniform sizes were generated using this system. By changing the 
flow rate of oil and aqueous phase, the diameter of the microdroplets ranged from 298.1 ± 9.3 μ m to 715 ± 8.9 μ m 
(Fig. 1c and Supplementary Movies 1–3). By modulating the flow rate of aqueous and oil phases, we were able 
to control the size of microbeads (Fig. 1c). To optimize the culture condition in collagen beads, we set the size 
to 500-μ m, a size that could enable the transport of sufficient oxygen, nutrients and metabolites to the cell 
(Supplementary Figure S3). Under these conditions, hundreds of spherical microbeads containing GC cells were 
obtained. The generated collagen microbeads are identified immunofluorescence staining by anti-type 1 colla-
gen (Fig. 1b), and microarchitecture of collagen hydrogels is observed by scanning electron microscopy (SEM) 
(Supplementary Figure S2). To optimize the cell concentration for a long-term 3D culture of a maximum of 10 
days, the density of the cells in the ECM beads was controlled by modulating the initial cell concentration, which 
ranged from 10 to 150 cells per bead (Fig. 1e and Supplementary Figure S4). After gelation, the oil layer was 
removed to avoid the issue of mass transport impairment of nutrients and metabolites for cell viability. Initially, 
the cells were randomly distributed and evenly scattered in each collagen bead. During cell growth, the sparse 
cells became denser and more compact (Supplementary Figure S5). Live/dead cell staining assays showed that 
most of the GC cells were alive in the collagen bead after 7 days (Fig. 1d).
Culture of gastric cancer cells in microbeads. Figure 2a shows the sequence of growth pattern for gas-
tric microtumor formation at 1, 3, 5 and 7 days. To investigate the cell morphology in 2D and 3D microtumors, 
F-actin was stained with TRITC-phalloidin (red), and nucleus was stained with DAPI (blue). The two types of 
GC cells exhibited significantly different morphologies during cell growth (Fig. 2a). AGS cells aggregated and 
formed a spheroid, whereas Hs746T remained segregated with scattered structures. The size of individual spheres 
of AGS in beads is increased from 12.8 μ m to 51.2 μ m for 7 days. The diameter of spheroids in collagen beads was 
51.2 ± 24.7 μ m after 7 days. For Hs746T in beads, the length of cell bodies was approximately 41.3 μ m to 149.2 μ m. 
In a single-cell-level analysis, we observed that gastric cancer cells had different cell migration and invasive pat-
terns depending on cell types (Fig. 2b and Supplementary Movies 4 and 5). AGS is spontaneously formed sphe-
roid by re-positioning daughter cells rather than by active migratory mobility. In contrast, Hs746T cells showed 
unique elongated dendritic morphology in collagen microbeads and exhibited a single-cell-level invasion and 
exhibited F-actin rich cellular protrusions (i.e., invadopodia).
Analysis of epithelial-mesenchymal transition (EMT). Next, we analyzed the EMT-related gene 
expression of epithelial (E-cadherin) and mesenchymal (N-cadherin, vimentin, and fibronectin) markers. For 
the epithelial marker E-cadherin, the relative mRNA expression levels were significantly (2.7- and 8.3-fold) higher 
in the adherent 2D platform than in the 3D platform of AGS and Hs746T, respectively. In contrast, 3D cultured 
cells showed increases in mesenchymal markers compared with the 2D monolayer culture (Fig. 2c). In addition, 
a significant increase of mesenchymal markers in Hs746T was identified. For mesenchymal markers, the relative 
mRNA expression levels of N-cadherin were 2.2- and 5.7-fold higher in the 3D models of AGS and Hs746T, 
respectively. The relative mRNA expression of vimentin was 3.7- and 2.6-fold higher in the 3D models of AGS 
and Hs746T. In the case of fibronectin, there were no major differences between 2D and 3D cultures, but there 
was a notable difference between the different cell lines, AGS and Hs746T. Immunofluorescence staining of AGS 
in collagen beads showed highly polarized spheroids, as indicated by E-cadherin (Fig. 3a). Western blotting was 
also performed to quantify EMT-related proteins. Figure 3b shows the correlations between the relative mRNA 
(Fig. 2c) and protein expressions. Although the results showed both intestinal and diffuse types, GC cells acquired 
mesenchymal traits at the molecular level, mRNA in 3D. It is also explained by mRNA profiling of matrix metallo-
protease (MMP) in 2D and 3D microtumors also supported these findings (Supplementary Figure S6).
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Analysis of drug resistance. We evaluated drug resistance in 3D compared with 2D with two different 
gastric cancer cell-lines by culturing with standard gastric cancer chemotherapeutic agents, 5-FU, which is a 
typical apoptosis-inducing agent. We performed a Live/dead cell staining and WST-1 proliferation assay to deter-
mine changes in cell viability in response to drug treatment (Fig. 4 and Supplementary Fig. S7). To evaluate 
the half maximal inhibitory concentration (IC50) of gastric cancer cells, we treated cells with 5-FU at different 
concentrations, ranging from 0 to 100 μ M, for 5 days after 1 day culture. Live/dead staining was conducted in 
2D and 3D microtumor depending on the drug concentration, ranged from 0 to 100 μ M. As shown in Fig. 4b, 
the drug concentration used was related to the change in cell viability. Although the survival rate was not sub-
stantially different between 2D and 3D at low concentrations (0.01 μ M to 0.1 μ M) of the drug, there was a dif-
ference in survival rate at high concentrations (10 μ M to 100 μ M). The 3D microtumor model exhibited more 
resistance to 5-FU at high concentrations of the drug. The IC50 of the 2D cultured AGS was 2-fold lower than 
that of the 3D microtumors, whereas the IC50 of Hs746T was approximately 10 μ M and was similar in 2D and 3D 
Figure 1. Formation of gastric microtumors. (a) Schematic illustration of forming gastric microtumors in 
microfluidic device. Cells encapsulated in collagen beads spontaneously form a size-controlled microtumors. 
(b) Immunofluorescence staining for type 1 collagen of collagen beads (red). (c) Image of generated microbeads 
and graphs by size distribution. By changing the flow rate of continuous and disperse phase, the size of 
microbeads controlled (n = 30–40). (d) Live/Dead staining of gastric cancer cells (AGS and Hs746T) in 
collagen microbead after 7 days. Live and dead cells were labelled with Calcein AM (green) and EthD-1 (red), 
respectively. (e) Images and graph of well-controlled cell concentration in microbead, 10, 50, and 150 cells per 
bead (n = 30–40). All scale bars: 300 μ m.
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Figure 2. Cell growth in microtumor over time for the two types of gastric cancer. (a) Confocal images 
of 2D- and 3D-cultured AGS (top) and Hs746T (bottom) at different times. Immunofluorescence images 
show overlap of F-actin (red) and the nucleus (blue). Scale bars: 100 μ m. (b) Sequences of images show the 
morphological features of gastric cancer cells in microtumors. Images were taken every 12 h. Intestinal-type 
cancer cells, AGS (top), present expansion growth forming cell aggregates, whereas diffuse-type cells, Hs746T 
(bottom), exhibit single-cell-level movement. Scale bar: 100 μ m. (c) Differences in gene expression between two 
types of cell. Epithelial-mesenchymal transition (EMT)-related genes, E-cadherin, vimentin, fibronectin, and 
N-cadherin, are targeted (n = 4–5, **:p < 0.01, ***:p < 0.001).
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(Supplementary Figure S7). Next, we treated cells with 5-FU for 7 days based on the IC50 (5 μ M) of AGS in 2D 
model (Supplementary Figure S8). AGS cells showed 68.8% and 90.6% survival upon drug treatment in 2D and 
3D cultures. On the other hand, Hs746T cells showed 87.2% and 94.7% survival after drug treatment, compared 
with the untreated control. A slight increase in survival of up to 7.5% was shown in the 3D microtumors com-
pared with the 2D culture.
Analysis of ß-catenin. To investigate drug resistance in the gastric cancer model, we targeted ß-catenin for 
potential predictive biomarkers for further validation. Also, we performed cytoskeleton and ß-catenin staining 
to determine changes in cell morphology in response to drug treatment (Fig. 5). Subsequently, we investigated 
the correlation between ß-catenin expression and chemosensitivity. As shown by RT-qPCR and western blotting 
(Fig. 5), the relative mRNA expression of ß-catenin in AGS was significantly decreased approximately 4.3-fold in 
the 3D model, whereas the relative mRNA expression of ß-catenin in Hs746T exhibited no difference between 
2D and 3D. In particular, the mRNA expression of ß-catenin was significantly decreased about 3-fold in Hs746T, 
compared AGS in 2D. These data indicate that reduced ß-catenin levels are associated with increased drug resist-
ance in gastric cancer cells (Fig. 5a,b). Cells surviving drug treatment exhibited decreased ß-catenin expression 
in cell lines cultured in 2D and 3D. Additionally, expression of ß-catenin translocated to the nucleus in cells sur-
viving 5-FU treatment (Fig. 5c).
Discussion
The approach of a microfluidic-based cell-laden scaffold has several advantages as a cell-culture model. For 
instance, microfluidic-based droplet formation allows us to precisely control the size of confinement as well as the 
density of cell seeding by adjusting the experimental parameters, such as flow velocity and concentration of cell 
suspension. In fact, both microbead size and cell density could affect the cell viability as well as the total concen-
tration of cell-released molecules due to limited diffusion. Therefore, identical and distinct properties could give 
rise to more efficient and accurate formation of tumor aggregates in 3D ECM with temporal and spatial control, 
as compared to other conventional bulk 3D systems. Furthermore, the microfluidic-based scaffold formation 
enables the establishment of rapid and high-throughput fabrication of microbead-based 3D tumors with small 
sample volumes. Therefore, we believe that a simple and well-characterized platform for the rapid formation of a 
3D tumor model could improve the 3D culture system in high-throughput drug testing and screening.
Compared with a 2D monolayer culture, the characterization of the 3D culture indicated differences in cell 
activity, including morphology, proliferation, and gene and protein expression. Based on our observations, the 
morphologic differences between intestinal (AGS) and diffuse (Hs746T) GC cell types are exhibited in this 
model. AGS had an expansive growth pattern with formation of well-organized spheroids. Hs746T acquired a 
fibroblast-like, spindle-shape morphology and showed active single-cell movement (Fig. 2a,b). It means that the 
Hs747T cells form extended protrusion and ECM adhesion. The morphological differences between the cell types 
are consistent with the features of in vivo GC cells. Histologically, intestinal type GCs cells have been character-
ized by cohesive gland-like tubular structures with an expanding growth pattern. In contrast, diffuse type GC 
consists of fewer or no cohesive cells and grown diffusely spread in the gastric wall.
During GC development, the activation of EMT plays an important role in progression, invasion and 
metastasis24. EMT is a process by which epithelial cells are converted into mesenchymal cells in the gastric 
mucosa, and it involves significant phenotypic changes such as the loss of cell-cell adhesion, cell polarity and 
the acquisition of migratory and invasive properties29. Adhesion of tumor cells to ECM components is a pivotal 
Figure 3. Expression of EMT-related proteins. (a) Representative immunofluorescence staining images 
of 2D gastric cancer cells, as well as 500-μ m collagen bead-based 3D cultures (7 days). Cross-sections were 
fluorescently labeled with antibodies targeting the epithelial marker, E-cadherin (green), and the mesenchymal 
marker, N-cadherin, fibronectin (red). Nuclei were counterstained with DAPI (blue). Scale bars, 50 μ m.  
(b) Immunoblot assays of gastric cancer cells in 2D and 3D after culturing for 7 days. Band signals were 
normalized to the GAPDH loading control.
www.nature.com/scientificreports/
6Scientific RepoRts | 7:41541 | DOI: 10.1038/srep41541
step in developing peritoneal dissemination of intra-abdominal malignancy and is accompanied by the EMT. It 
is well-known that the diffuse type gastric cancer exhibits defective intercellular adhesion, primarily as a conse-
quence of the loss of E-cadherin expression30. Moreover, the diffuse-type cancer exhibits altered expression of 
genes related to cell-matrix interactions and ECM components, whereas intestinal-type GC is represented by the 
enhancement of cell growth and maintenance of cell-cell interaction24.
As shown in Fig. 2, we observed the morphological changes in GC cells in the collagen beads. In particular, 
Hs746T cells had typical morphologic mesenchymal phenotypes. In addition to two morphologically different 
variants, diffuse-type and intestinal-type gastric cancer may also show differences in the genetic feature such as 
expression of the EMT regulators. The loss of functional E-cadherin in gastric cancer has been described in up to 
50% of cases of diffuse-type gastric cancer, but not in the intestinal type31. In addition, the upregulation of mes-
enchymal markers has been observed in the diffuse type. These results suggest the existence of distinct carcino-
genetic pathways for the intestinal and diffuse type carcinoma. Our RT-qPCR results confirmed that E-cadherin 
expression was significantly reduced, and expression of mesenchymal markers was upregulated in Hs747T when 
compared with the AGS (Fig. 2c). These findings indicate that the mode gastric microtumors reflect the charac-
teristics of their in vivo gastric cancer counterparts, such as cell morphology and EMT-related gene expression.
Recently, EMT has been found to play a critical role in the cancer drug resistance, metastasis and poor 
prognosis of GC32. In this study, we determined that gastric cancer cells (AGS and Hs746T) undergo EMT 
Figure 4. Evaluation of chemosensitivity in microtumor. (a) Live/dead staining of gastric cancer cells 
encapsulated in collagen beads after two days treatment at several 5-FU concentrations. Live and dead cells 
were stained with calcein AM (green) and EthD-1 (red) respectively. Scale bars: 50 μ m. (b) Survival rate of AGS 
(right) and Hs746T (left) using WST1 proliferation assay (n = 3, blue line: 2D control, red line: 3D microtumor).
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and promoted cell migration and invasion through the β -catenin pathway. A variety of signalling pathways are 
related to the EMT induction, including tumor growth factor-β (TGF-β ), nuclear factor-κ B, Notch, RTK/Ras 
and Wnt/β -catenin29,33. In particular, ß-catenin signalling pathway plays an important role in EMT and drug 
resistance32. On the basis of the results, we speculated that EMT may be involved in the development of drug 
resistance that exhibit a negative correlation with the expression of ß-catenin.
In drug resistance tests, we determined the half maximal inhibitory concentration (IC50) against of 
5-fluorouracil(5-FU), which is a commonly used chemotherapeutic agent for treating malignant GC24. Compared 
with AGS, Hs746T showed more malignancy and resistance to the 5-FU, with an approximately 2-fold of mag-
nitude higher IC50. Drug resistance was increased in 3D microtumors compared with 2D, with significant differ-
ences at high concentration of drug (Fig. 4). Figure 4 represent that intestinal AGS cells acquire drug resistance 
when cultured in 3D while diffuse Hs746T cells maintain relatively similar characteristics. On the other hand, 
diffuse Hs746T cells did not undergo drastic changes in drug resistance; it could be speculated that diffuse type 
cells already exhibit cell-intrinsic drug resistance property. In addition, a substantial decrease in total ß-catenin 
levels in drug-resistant cells was observed, which likely resulted from the development of a mesenchymal phe-
notype associated with the loss of E-cadherin/β -catenin-associated adherent junctions. Subsequently, the lower 
expression of ß-catenin is associated with regulation of EMT for the progression of GC and drug resistance. Such 
a phenomenon has previously been shown to be involved in metastatic gastric cancer34. Indeed, the increased 
nuclear β -catenin level was observed by immunofluorescence staining (Fig. 5c) and was associated with increased 
drug resistance and decreased β -catenin expression. That is nuclear β -catenin is related high drug resistance and 
decreased expression of total β -catenin. Through β -catenin inhibitor, PNU-74654, we observed inhibition of 
nuclear transportation of β -catenin reduced drug resistance (Supplementary Figure S9).
Taken together, we demonstrated that distinct genotypic and phenotypic characteristics were associated with 
two different pathological variants of GC. According to the in vivo-like characteristics, we propose that gastric 
microtumors represent a physiologically relevant in vitro model to study EMT-mediated drug resistance in gastric 
cancer. The differences in the pathological behaviors of both types are of practical significance in decision making 
about appropriate treatment options in GC.
In summary, this study reports that a microdroplet-based 3D gastric cancer model provides a valuable 3D 
tumor microenvironment. Using our in vitro 3D GC models, we investigated different cellular responses between 
pathological variants of GC. Furthermore, we confirmed that the expression levels of ß-catenin were correlated 
with drug resistance. We believe that our microtumor platform could provide a better understanding of ECM-cell 
interactions and cancer invasion, and evaluate drug-resistant cancer in a controlled microenvironment.
Methods
Preparation of microfluidic devices. Microfluidic polydimethylsiloxane (PDMS) devices were fabricated 
by photolithography and soft lithography. The device design was drawn in AutoCAD to be used as photomask. 
The microfluidic device is functionally composed of an aqueous channel with gastric cancer cells, collagen solu-
tion and oil (Supplementary Figure S1). Dimension of device is described in detail in Supplementary Figure 1. 
Patterned silicon mold of 100 μ m in height was prepared from SU-8 2100 (MicroChem) according to protocol. 
Figure 5. Expression of ß-catenin in gastric microtumors. (a) mRNA analyses of ß-catenin in 2D and 3D 
cultures of AGS (left) or Hs746T (right), with and without 5-fluorouracil (5-FU)] treatment. N = 4–5. **: 
p < 0.01, *: p < 0.05. (b) Western blot analysis of ß-catenin expression in AGS (left) and Hs746T (right) cells in 
2D and 3D cultures with and without drug treatment. Band signals were normalized to the GAPDH loading 
control. (c) Cell morphology following 5-FU treatment in 2D and 3D cultures. Colored images represent the 
merge of F-actin (red) and nucleus (blue) staining (top). For immunofluorescence staining images of ß-catenin 
following 5-FU treatment, the colored images represent the merge of ß-catenin (red) and nucleus (blue) staining 
(bottom). Scale bars, 100 μ m.
www.nature.com/scientificreports/
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PDMS prepolymer and curing agent (Sylgard 184 Silicon Elastomer Kit, Dow Corning) were mixed at 10:1 ratio 
before poured on silicon mold. After curing at 70 °C for 2 hours, PDMS was peeled off from the mold before holes 
at inlets and outlets were punched. A flat PDMS sheet was bonded with the device after oxygen plasma treatment 
(Femto Science, Cute) for 30 s.
Gastric cancer cell culture. The gastric cell lines, AGS and Hs746T, were obtained from Yonsei University. 
The gastric cancer cells were cultured in RPMI1640 media at 37 °C in a humidified incubator with 5% CO2. The 
culture dish is used size of 100 × 20 mm (SPL Life technology). The culture medium was supplemented with 10% 
fetal bovine serum (FBS, Welgene) and 1% penicillin/streptomycin (Welgene). AGS and Hs746T were subcul-
tured by trypsin/EDTA (0.25%, Welgene). The culture media were changed every 2~3 days.
Generation of cell-laden collagen beads (microtumors). Collagen type 1 (Rat tail, Corning) was 
diluted and neutralized to 4 mg/ml in ice bath to prevent gelation35. Collagen stays liquid at 4 °C but self-assembles 
into a gel at 37 °C. To generate a biocompatible procedure for forming cell-laden microdroplets, we utilized a 
fluorinated oil (HFE7500) as oil phase, which has high oxygen permeability to ensure an adequate supply of 
oxygen during collagen gelation. Collagen microdroplets formed at the cross-junction by flow focusing with a 
continuous stream of low-viscosity fluorocarbon oil, HFE7500 (3 M Novec, Singapore), loaded with 2 wt% sur-
factant, 008-FluoroSurfactant (Ran biotechnology, USA). During injection, the syringe filled with the collagen 
solution was covered with an ice bag to prevent gelation of collagen. Droplets were generated in a microfluidic 
channel using a syringe pump (70-4506INT; Harvard Apparatus, Holliston, MA, USA) and a Teflon tube (inner 
diameter, 0.02 inches; outer diameter, 0.06 inches). The microdroplets spontaneously formed at a cross junction 
due to their different interfacial properties. First, 4 mg/ml collagen type 1 with GC cells and oil were injected into 
the device. The optimal flow rates for the formation of stable 500-μ m microbeads were 4 μ L/min for a cell-laden 
ECM solution channel and 10 μ L/min for an oil channel. The optimal flow rates for the formation of stable 300- 
and 700-μ m microbeads were 5 μ L/min for a cell-laden ECM solution channel and 13 and 20 μ L/min for an oil 
channel, respectively. Droplets were collected externally in an Eppendorf tube at outlet part, and incubated at 
37 °C incubator to make collagen beads. After 30 min at 37 °C, the microtumors were released using a droplet 
releasing agent (1H,1H,2H,2H-perfluoro-1-octanol) from Sigma-Aldrich27,36–38. In a sterilized tube, the droplet 
releasing agent and microtumors (variable volume) were added sequentially, and left at RT for 5 minutes. The 
released microtumors in aqueous phase was then retrieved. Retrieved microtumors are cultured in RPMI1640 
media at 37 °C in a humidified incubator with 5% CO2 for 7 days, and the medium was changed every 2~3 days, 
same as 2D cultured.
Cell viability assay. Cells cultured in 2D and 3D microbeads were suspended in PBS and mixed with Live/
Dead viability/cytotoxicity kit (Life technology), consisting of Calcein AM (4 mM) and ethidium homodimer-1 
(EthD-1, 2 mM). Live/Dead staining solution (2 μ M Calcein AM and 4 μ M EthD-1 in PBS) was introduced into 
2D and 3D cultured gastric cancer cells for 20 min at room temperature. The viability was indicated by green (live) 
or red (dead) fluorescence labelled cells. Live and dead cells observed by measuring fluorescence signal using laser 
scanning confocal microscopy (Nikon).
Immunofluorescent staining. Cultured cells in 2D and 3D were fixed with 4% paraformaldehyde solution 
(Biosesang, Korea), and permeabilized with 0.15% Triton-X100 (Sigma-Aldrich) in PBS. And then cells were 
blocked with 2% bovine serum albumin (BSA, Sigma-Aldrich) in PBS for 1 h at RT. After blocking, cancer cells in 
2D and 3D were incubated with the antibody diluted in PBS with 1% BSA. F-actin and nucleus of cells was stained 
with TRITC-phalloidin (1:1000, Sigma-Aldrich) and DAPI (1:2000, Sigma-Aldrich) for 20 min at RT. For immu-
nostaining of EMT and drug resistant-related proteins, cancer cells were incubated with anti-ß-catenin (1:200, 
Abcam), E-cadherin (1:100, Abcam), N-cadherin (1:150, Abcam), and Fibronectin (1:150, Abcam) overnight at 
4 °C. Subsequently, TRITC-conjugated secondary antibody (dilution 1:500) and FITC-conjugated secondary anti-
body (dilution 1:500) was incubated for 3 hours at room temperature. Fluorescence images were acquired using 
laser scanning confocal microscopy (Nikon).
Total RNA extraction from gastric cancer cells in 2D and 3D culture. The mRNA expression asso-
ciated with EMT and drug resistance was analyzed by RT-qPCR. To obtain samples for reverse RT-qPCR, cells 
in 2D and 3D were cultured on a cell culture dish (100 × 20 mm; SPL Life Sciences, Pocheon, Korea). To analyze 
cell proliferation and drug resistance, cells were cultured in 96-well plates. For the harvesting of cells and RNA 
extraction, 2D-cultured cells were scraped off the dish bottom using a cell scraper. 3D microtumors were carefully 
collected using a pipette. Then, 2D- and 3D-cultured samples were homogenized by hand using a tissue grinder 
on ice. Isol RNA lysis reagent (5 Prime, Hilden, Germany) was used to extract total RNA from cells in accordance 
with the manufacturer’s instructions. Samples were mixed with this reagent, followed by phase separation using 
chloroform. After collection of the aqueous phase, RNA was precipitated by treatment with isopropyl alcohol and 
glycogen for 1 h at − 20 °C. Extracted RNA was collected and washed with 70% ethanol three times, followed by 
dehydration. Dried RNA was dissolved in a suitable amount of diethylpyrocarbonate water. The concentration of 
total RNA was determined by measuring the absorbance at 260 nm using a spectrophotometer. Only RNA sam-
ples with A260/A280 ≥ 1.8 were used. Samples were stored at − 20 °C until future use.
Quantitative real time reverse transcription-polymerase chain reaction (RT-qPCR) analy-
sis. Total RNA (1 μ g) was reverse-transcribed into cDNA by the iScript cDNA synthesis kit (Bio-Rad, Hercules, 
CA, USA). RT-qPCR were performed in a thermal cycler using SYBR Green Real-time PCR Master Mix (Toyobo, 
Osaka, Japan). RT-qPCRs were conducted using primers for ß-catenin; Forward: 3′ -GCT GAT TTG ATG GAT 
GGA GTT GG-5′ , Reverse: 3′ -CTA CTT GTT CTT GAG TGA A-5′ , N-cadherin; Forward: 3′ -TTT GAG GGC 
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ACA TGC AGT AG-5′ , Reverse: 3′ -ACT GTC CCA TTC CAA ACC TG-5′ , E-cadherin; Forward: 3′ -GTG ACT 
GAT GCT GAT GCC CCC AAT ACC-5′ , Reverse: 3′ -GAC GCA GAA TCA GAA TTA GGA AAG CAA G-5′ , 
Vimentin; Forward: 3′ -GAA ATT GCA GGA GGA GAT GC-5’, Reverse: 3′ -CGC ATT GTC AAC ATC CTG 
TC-5′ , and Fibronectin; Forward: 3′ -ATG AGC TGC ACA TGT CTT GG-5′ , Reverse: 3′ -TGG CAC CGA GAA 
TTC CTT C-5′ . The expression levels were normalized to those of GAPDH; Forward: 3′ -GTA TGA CAA CAG 
CCT CAA GAT-5′ , Reverse: 3′ -AGT CCT TCC ACG ATA CCA AA-5′ . Quantification was based on the expres-
sion of the target genes relative to that of the housekeeping gene GAPDH as a reference (endogenous control). 
The normalized value was then expressed as the ratio relative to that in the 2D monolayer group.
Western blot. Cells were lysed in 1X RIPA buffer (Sigma-Aldrich) supplemented with Halt™ Protease 
and Phosphatase Inhibitor Cocktail (ThermoFisher Scientific). The protein concentration was determined by 
Bradford method with BSA (Sigma-Aldrich) as the standard. Equal concentration of protein extract were sub-
jected to 12% SDS-PAGE and transferred to PVDF membrane. Blots were labelled with the primary antibodies, 
ß-catenin (1:1000, Abcam), and GAPDH (1:2000, Sigma). GAPDH was used as a loading control. And following 
day, HRP-conjugated secondary antibody (1:5000, Sigma-Aldrich) was added to the blot for 3 hours at RT. Protein 
expression was detected using ECL western blotting detection reagent (Bio-Rad, Hercules, CA, USA) and mem-
branes were imaged using an imaging system (ImageQuant LAS 4000 mini, GE Healthcare).
Drug resistance experiments. Both AGS and Hs746T grown on culture dish and in collagen bead for 
5days were treated with 5-FU in various concentrations. 5-FU were obtained from Yonsei University. To analyze 
drug resistance, we used 1 × 103 cells/well in 2D culture and approximately 20 beads/well in 3D microtumor 
culture (50 cells per collagen bead). After 5 days of incubation, surviving cells were examined by the WST-1 assay 
(Roche Diagnostics, Mannheim, Germany). In all, 1 × 103 cells were seeded into 96-well plates, and allowed to 
adhere to the dish or ECM for 24 h, at which point 0.01 μ M to 100 μ M 5-FU was administered. WST-1 solution 
was added to the cells, incubated at 37 °C for 2 h, and the signal measured using XMark microplate spectropho-
tometer (Bio-Rad, Hercules, CA, USA). The survival rate at different 5-FU concentrations were normalized to the 
measured value at 0 μ M 5-FU.
Statistical analysis. For all statistical analysis, the normalized values from independent experiments were 
averaged and expressed as mean ± standard error (SE). Data sets were statistically analysed for significance using 
two-tailed Student’s t-tests. In graph of Figs 2, 5 and S6, p-values are denoted with either asterisks (*) as follows: 
*:significant at p < 0.05, **:significant at p < 0.01, and ***:significant at p < 0.001.
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